José D. Abdullatif

José D. Abdullatif

Auto-generated profile, based on publicly available information

José D. Abdullatif

Departamento de Otorrinolaringología Hospital Británico de Buenos Aires Ciudad Autónoma de Buenos Aires Argentina

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2026 in World Journal of Otorhinolaryngology - Head and Neck Surgery
Verified
Journal Article
Open access
Diego Marcelo ContiDiego Marcelo Conti
Diego Marcelo Conti
ECEduardo Javier Correa
Eduardo Javier Correa
Alfonso Del Cuvillo BernalAlfonso Del Cuvillo Bernal
Alfonso Del Cuvillo Bernal
JAJosé D. Abdullatif
José D. Abdullatif
FAFrancisco Javier Alvarez-gutierrez
Francisco Javier Alvarez-gutierrez
Juan Maza-SolanoJuan Maza-Solano
Juan Maza-Solano
Background: Chronic respiratory diseases impose a large global burden of morbidity, mortality, and cost. The concept of a global airway has become increasingly supported by epidemiologic, mechanistic, and clinical evidence. However, clinical care often remains fragmented between ear, nose, and throat (ENT), allergy, and pulmonology. Methods: A multidisciplinary expert panel composed of allergists, pulmonologists, and otolaryngologists from multiple tertiary care centres was convened. Experts were selected using predefined criteria encompassing clinical experience, academic output, geographic and institutional diversity, and gender balance. The panel performed a structured synthesis of current international guidelines and high‐impact literature, using a modified Delphi consensus process over 3 rounds, with a predefined agreement threshold of ≥ 80% to define the scope of diseases, diagnostic approach, and interdisciplinary care model. Results: The Global Airways Unit (GAU) framework prioritizes multidisciplinary teamwork, early detection of comorbidities, phenotype‑directed investigations, streamlined imaging, and assignment of a lead specialty with scheduled follow‑up. Expected benefits include earlier diagnosis, improved disease control and quality of life (QoL), reduced duplication of testing, and potential cost‑savings for patients and health systems. Conclusions: The GAU operationalises the unified airway hypothesis into a reproducible clinical model. We propose the formation of a GAU to coordinate the management of patients with inflammatory airway diseases. Prospective real‑world evaluation of GAU implementation is the next critical step to validate clinical and economic outcomes.